About US
Contact us
>>Back
Organisational structure 'key to pharma compliance'
- Publisher：
- Publication：2012/10/30
With only a quarter of leading pharmaceutical companies having centralised their compliance departments, new research suggests that organisational structure is crucial to improving these efforts.
According to the study, by Cutting Edge Information, compliance is considered critical to both brand and corporate success in the pharmaceutical industry.
For this reason, high-level leaders are often placed in charge of compliance efforts, with recent government audits suggest the focus is now shifting to building better compliance structures across organisations instead.
"Compliance is something of a buzzword used by many functions within drug companies," said Ryan McGuire, research team leader at Cutting Edge Information.
"From marketing to clinical operations to medical affairs groups, they all understand the potential consequences of failing compliance standards."
He said that pharmaceutical leaders must now reexamine the ways that their companies manage compliance efforts, with centralisation offering an opportunity to ensure that this function is close to the strategic centre of the business.